by Clinical Neuropsychologist | Wednesday, June 19, 2024 | Dementia
Abstract INTRODUCTION Long-term blood pressure variability (BPV) and plasma neurofilament light (pNfL) have been identified as potential biomarkers for Alzheimer’s disease (AD) and cerebral small vessel disease (CSVD). However, the relationship between BPV,...
by Clinical Neuropsychologist | Wednesday, June 19, 2024 | Dementia
Abstract BACKGROUND We investigated the effects of apolipoprotein E (APOE) ε4 and its interactions with sociodemographic characteristics on cognitive measures in South Asians from the Diagnostic Assessment of Dementia for the Longitudinal Aging Study of India...
by Clinical Neuropsychologist | Wednesday, June 19, 2024 | Dementia
Abstract INTRODUCTION Despite prior research on the association between sarcopenia and cognitive impairment in the elderly, a comprehensive model that integrates various brain pathologies is still lacking. METHODS We used data from 528 non-demented older adults with...
by Clinical Neuropsychologist | Tuesday, June 18, 2024 | Dementia
Dementia, Volume 23, Issue 6, Page 1021-1035, August 2024. Objectives: This study aimed to understand the care needs, care arrangements and burden of care for people with dementia in Northern Tanzania. Methods: This was a cross-sectional, observational study. People...
by Clinical Neuropsychologist | Tuesday, June 18, 2024 | Dementia
Abstract INTRODUCTION Corticobasal syndrome (CBS) can result from underlying Alzheimer’s disease (AD) pathologies. Little is known about the utility of blood plasma metrics to predict positron emission tomography (PET) biomarker-confirmed AD in CBS. METHODS A...
